Bladder Cancer - Results from #140

C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma. April 7, 2022

Diagnostic accuracy and discriminative power of biparametric versus multiparametric MRI in predicting muscle-invasive bladder cancer. April 7, 2022

Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer. April 7, 2022

The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness. April 7, 2022

Prognostic impact of insulin-like growth factor-I and its binding proteins, insulin-like growth factor-I binding protein-2 and -3, on adverse histopathological features and survival outcomes after radical cystectomy. April 6, 2022

Long-term Health-related Quality of Life (HRQOL) After Radical Cystectomy and Urinary Diversion - A Propensity Score-matched Analysis. April 6, 2022

Altered Urine Metabolome in Patients with Bladder Cancer - Expert Commentary April 5, 2022

Human Epidermal Growth Factor Receptor 2 (HER2) and Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations to Reveal Biological Pathways in Urothelial Carcinoma April 5, 2022

Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. April 5, 2022

The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program. April 5, 2022

Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer. April 4, 2022

Cognitive function in patients undergoing cystectomy for bladder cancer - results from a prospective observational study. April 4, 2022

Reduced-dose bacillus Calmette-Guérin (BCG) in an era of BCG shortage: real-world experience from a tertiary cancer centre April 1, 2022

Recurrence Mechanisms of Non-Muscle-Invasive Bladder Cancer — a Clinical Perspective April 1, 2022

Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario. April 1, 2022

Histological variants of non-muscle invasive bladder cancer: Survival outcomes of radical cystectomy vs. bladder preservation therapy. April 1, 2022

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. March 31, 2022

Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors. March 31, 2022

Disparities in patient and system factors explain racial/ethnic disparities in delayed time to treatment in muscle invasive bladder cancer. March 30, 2022

[Does robotic radical cystectomy affect oncological outcomes in bladder cancer patients?] March 30, 2022

Page 8 of 431

email news signup